Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discovery
Bioorganic Chemistry · 2026-08 · 178 · 109979
DOI: 10.1016/j.bioorg.2026.109979 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2026-08. Verfasst von Rajarshi Nath und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Bharat Technology, Uluberia, Howrah, West Bengal 711316, India; Department of Pharmaceutical Technology, JIS…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Oxazoles, Antineoplastic Agents, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Protein kinases are hubs in oncogenic regulation that transmit messages of cell proliferation, survival, migration, and metastasis, and can hence be considered verified targets in cancerous treatment today. Nevertheless, the drawbacks of some of the already approved kinase inhibitors, like poor selectivity, dose-limiting toxicities, and resistance, remain to foster new scaffolds and ideal chemotypes. Oxazole is a privileged five-membered heteroaromatic ring comprised of nitrogen and oxygen that has found broad application in anticancer drug discovery due to its desirable electronic properties, drug-like nature and its ability to make key interactions with the kinase ATP-binding sites. We have reviewed in detail the recent advances in oxazoles and benzoxazole analogues that have been discovered as inhibitors of key cancer-relevant tyrosine kinases, such as VEGFR-2, EGFR, CDK2, MAPKs, and other receptor/non-receptor tyrosine-kinase targets. We also present synthetic strategies that are representative, a trend of structure-activity relationship (SAR), and molecular docking evidence that can be used to explain potency and selectivity, hinge bonding, and conserved residue binding that can be commonly seen in most targets. This review incorporates a combination of chemical design theory and biological performance by enumerating the role of oxazole-based hybrids and optimal patterns of replacement in enhancing antiproliferative action in various cancer cell entities. We conclude by finally highlighting areas of concern, as well as future opportunities of the translation of oxazole-derived kinase inhibitors, such as enhancing the selectivity of kinase activity, improving resistance to its activities, and enhancing the ADME/toxicity profiles, to clinically relevant anticancer candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, Howrah, West Bengal 711316, India; Department of Pharmaceutical Technology, JIS University, Agarpara Campus, 81- Nilgunj Road, Agarpara, Kolkata 7001…
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, Howrah, West Bengal 711316, India. Electronic address: biplab.d86@gmail.com.
- Department of Pharmaceutical Technology, Bharat Technology, Uluberia, Howrah, West Bengal 711316, India.
- Department of Pharmaceutical Chemistry, National University of Science and Technology, PO-620, PC-130, Azaiba, Bousher, Muscat, Sultanate of Oman.
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India.
- Department of Academics, Sumandeep Vidyapeeth, Deemed to be University, Vadodara 391760, Gujarat, India; Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand 248002, India.
Zitieren
APA
Nath, R., Debnath, B., Maity, I., Ashique, S., Chakraborty, A., Akhtar, M. J., Nehra, B., Tariq, M., Ansari, M. Y., & Maity, A. (2026). Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discovery. Bioorganic Chemistry, 178, 109979. https://doi.org/10.1016/j.bioorg.2026.109979
Vancouver
Nath R, Debnath B, Maity I, Ashique S, Chakraborty A, Akhtar MJ, et al. Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discovery. Bioorganic Chemistry. 2026;178:109979. doi:10.1016/j.bioorg.2026.109979
BibTeX
@article{Nath2026,
author = {Nath, Rajarshi and Debnath, Biplab and Maity, Indrajit and Ashique, Sumel and Chakraborty, Anhic and Akhtar, Md Jawaid and Nehra, Bhupender and Tariq, Mohd and Ansari, Md Yousuf and Maity, Arindam},
title = {Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discovery},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {178},
pages = {109979},
doi = {10.1016/j.bioorg.2026.109979}
}
EUVIMED